Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice

2015/02/19 by Hongyun Li, Kalani Ruberu, Sonia Sanz Muñoz +12 · 2 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Alzheimer's disease #Alzheimer's disease research and treatments #Amyloid (mycology) #Amyloid precursor protein #Amyloidosis: Diagnosis, Treatment, Outcomes #Apolipoprotein B #BACE1-AS #Biochemistry #Biology #Cholesterol #Disease #Endocrinology #Gene #Genetically modified mouse #Hippocampal formation #Immunohistochemistry #Medicine #Pancreatitis Pathology and Treatment #Pathology #Senile plaques #Transgene

paper · doi:10.1016/j.neurobiolaging.2015.02.010

openalex publication_date 2015/02/19 · crossref created 2015/02/19 · crossref issued 2015/05/01 · crossref published 2015/05/01 · crossref published-print 2015/05/01 · crossref deposited 2022/04/30 · openalex created_date 2025/10/10 · crossref indexed 2026/07/09 · openalex updated_date 2026/07/28

Citations

• Modulation of apolipoprotein D expression and translocation under specific stress conditions
• Binding properties of Progesterone-Binding Cyst Protein, PBCP
• Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex
• Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
• Arachidonic acid binds to apolipoprotein D: implications for the protein's function
• Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase

Cited by

• Apolipoprotein D
• Apolipoprotein D [wikipedia]